Cyrus Biotechnology
PrivateLast Round
Seed Round
May 8, 2026
Total Funding Raised
$27.15M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cyrus Biotechnology is a biotechnology company that develops AI-driven protein engineering technologies to create novel protein therapeutics for autoimmune diseases and other challenging drug targets.
Sector
Enterprise Software
Verticals
Biotechnology, Drug Discovery, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyrus Biotechnology Comparables
Compare Cyrus Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OpenProtein.AI | 82% | |
| ProteinQure | 79% | |
| Cradle | 77% | |
Cyrus Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 8, 2026 | ||||
| Grant | Sep 15, 2022 | ||||
| Series B | Dec 6, 2021 | ||||
| Series A | Jul 27, 2017 | ||||
| Seed | Jun 2, 2015 |
Key People
Founding team and executive leadership
Cyrus Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series B |
| iSelect Fund | Series B |
| National Institute of Allergy and Infectious Diseases | Grant |
| The Yard Ventures | Series B |
| OrbiMed | Series A, Series B |
| Washington Research Foundation Capital | Series A, Series B |
| SpringRock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 7, representing 41% of headcount.
- May 8, 2026
$1.48M raised in Seed Round.
Cyrus Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cyrus Biotechnology's valuation, stock price, and market status.